FDA product code DDH: Carbonic Anhydrase B, Antigen, Antiserum, Control
DDH is the FDA product code for carbonic anhydrase b, antigen, antiserum, control. It is a Class I device, regulated under 21 CFR 866.5200 and reviewed by the Hematology panel. Devices under DDH reach the market by 510(k) exempt; FDA lists no cleared 510(k)s for it.
Classification
| Field | Value |
|---|---|
| Device name | Carbonic Anhydrase B, Antigen, Antiserum, Control |
| Device class | Class I |
| Regulation | 21 CFR 866.5200 |
| Review panel | HE — Hematology |
| Medical specialty | Immunology |
| Premarket route | 510(k) exempt |
Recalls for DDH devices
openFDA lists no recalls for product code DDH.
Frequently asked questions
What is FDA product code DDH?
DDH is the FDA product code for carbonic anhydrase b, antigen, antiserum, control. It is a Class I device, regulated under 21 CFR 866.5200 and reviewed by the Hematology panel.
What device class is DDH?
Class I, regulation 21 CFR 866.5200. Typical premarket route: 510(k) exempt.
Next steps
- Run an FDA pathway report with predicate devices for product code DDH
- Run a recall and safety report across every DDH manufacturer
- Watch product code DDH for new clearances and recalls
Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.
All Hematology product codes · FDA product code lookup · 510(k) database search · 510(k) review times